Autologous human adipose tissue derived bone tissue therapy (Bonus BioGroup)

N/A

Report date: 2023/01/12 15:46:51

Base Information

Drug NameAutologous human adipose tissue derived bone tissue therapy (Bonus BioGroup)
Drug Alias NameBonoFillHATDCsBonoFill-IIBone graft for maxillofacial applicationsHuman Adipose Tissue Derived Cells
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionTissue replacements
TargetsNot applicable
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBonusbio Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBonusbio Group Ltd
Inactive CompaniesN/A
Active IndicationsBone Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A